Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability
出版年份 2021 全文链接
标题
Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability
作者
关键词
CD31, Angiogenesis, Vascular survival, Endometrial cancer, Tumor infiltrating lymphocytes, CD25, FOXP3
出版物
IMMUNOBIOLOGY
Volume 226, Issue 3, Pages 152078
出版商
Elsevier BV
发表日期
2021-03-07
DOI
10.1016/j.imbio.2021.152078
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
- (2020) Elena García-Martínez et al. ANGIOGENESIS
- Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy (Review)
- (2020) Lei Zhan et al. Oncology Letters
- Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
- (2020) Won Suk Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Antiangiogenic therapy: Markers of response, “normalization” and resistance
- (2018) Karima El Alaoui-Lasmaili et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effects of different hypoxia degrees on endothelial cell cultures—Time course study
- (2018) Ioana Baldea et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Improvements in Progression-Free and Overall Survival Due to the Use of Anti-Angiogenic Agents in Gynecologic Cancers
- (2015) Bernd C. Schmid et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
- (2015) Jee H. Lee et al. IMMUNITY
- Tumor Vasculature Is Regulated by FGF/FGFR Signaling-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs
- (2014) Pierre Fons et al. JOURNAL OF CELLULAR PHYSIOLOGY
- In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model
- (2012) XIAOHUI DU et al. ONCOLOGY REPORTS
- Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
- (2012) E. T. Clambey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New pathways and mechanisms regulating and responding to Delta-like ligand 4–Notch signalling in tumour angiogenesis
- (2011) Chern Ein Oon et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy
- (2009) Joshua I Greenberg et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α
- (2008) Jeremy Ben-Shoshan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer
- (2008) Alexandra Giatromanolaki et al. GYNECOLOGIC ONCOLOGY
- Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment
- (2008) Pierre Sonveaux RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started